Safety, Performance and Usability of BALT Medical Devices: The EVIDENCE Post Marketing Clinical Follow-up Platform
EVIDENCE
1 other identifier
observational
10,000
3 countries
12
Brief Summary
BALT has designed an electronic platform to continue collecting clinical data as part of the post-marketing clinical follow-up of its devices. This platform is purely exploratory, without hierarchical order of the objectives and associated outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2021
Longer than P75 for all trials
12 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 9, 2021
CompletedFirst Posted
Study publicly available on registry
June 15, 2021
CompletedStudy Start
First participant enrolled
July 12, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2041
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 1, 2041
September 18, 2025
September 1, 2025
19.9 years
June 9, 2021
September 16, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Rate of occurrence of device-specific safety indicator(s).
Specific outcomes will be adapted accordingly for each device family since the intended use will vary according to the device families.
From the procedure to 12 months post-procedure depending on the device family.
Rate of devices achieving its intended use.
Specific outcomes will be adapted accordingly for each device family since the intended use will vary according to the device families.
From the procedure to 12 months post-procedure depending on the device family.
Rate of devices achieving its specific performance indicator(s).
Specific outcomes will be adapted accordingly for each device family since the intended use will vary according to the device families.
From the procedure to 12 months post-procedure depending on the device family.
Rate of devices in each category of the usability scale (Likert-type scale) for each usability indicator
Qualitative measurement of usability for each usability indicator (i.e., good, well adapted, fairly adapted, bad). Specific outcomes will be adapted accordingly for each device family since the intended use will vary according to the device families.
From the procedure to 12 months post-procedure depending on the device family.
Study Arms (1)
BALT medical devices
Interventions
Includes, but is not limited to, the following: * Access devices * Aneurysm treatment devices * Ischemic Stroke and peripheral occlusive diseases treatment devices * Arterio-Venous Malformations/fistulas treatment devices
Eligibility Criteria
The study population will include the BALT medical devices under consideration used in their respective indications for use during interventions performed at the participating sites.
You may qualify if:
- Provision of a signed, written and dated informed consent or non-opposition (where applicable)
You may not qualify if:
- Device(s) used in multiple procedures (two, or more, pathologies treated during the same procedure)
- Contra-indications of each device as described in the instructions for use.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Balt Extrusionlead
Study Sites (12)
CHU Angers
Angers, France
Chu Bordeaux
Bordeaux, France
CHU Grenoble Alpes
La Tronche, France
Hôpital Roger Salengro
Lille, France
Kremlin Bicêtre - APHP
Paris, France
Chu Tours
Tours, 37000, France
Halle
Halle, Germany
Hospital: Fundacion Jimenez Diaz
Madrid, 28222, Spain
Hospital Clinico Universitario San Carlos
Madrid, Spain
Unversitario Central de Asturias
Oviedo, 33011, Spain
Hospital Universitario Marqués de Valdecilla (HUMV)
Santander, Spain
Hospital Universitario Miguel Servet
Zaragoza, Spain
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 9, 2021
First Posted
June 15, 2021
Study Start
July 12, 2021
Primary Completion (Estimated)
June 1, 2041
Study Completion (Estimated)
October 1, 2041
Last Updated
September 18, 2025
Record last verified: 2025-09